key mechanisms of alpha-synuclein in parkinson's disease: fibril formation & cell-to-cell transmission


abl301: first-in-class bbb penetrating bispecific antibody for targeting alpha-synucle

pipeline-301.021
pipeline-301.022

key differentiation of abl301


competitive advantages of abl301